September Nobel Peace Prize Winner to deliver public lecture on nuclear weapons

Nobel Peace prize winner Dr James E Muller will deliver a public lecture at University of Galway on the issue of nuclear weapons and the threat of nuclear war.

The talk, entitled Nuclear Weapons and the Future of Humanity- a fifty year perspective, will take place at the University’s O’Donoghue Centre for Drama Theatre and Performance on Monday September 26 at 5pm.

Dr Muller is an academic cardiologist and entrepreneur who has worked to prevent three threats to humanity - nuclear war, heart attacks and sexual abuse of children by priests.

In 1980 Dr Muller was one of the founders of International Physicians for Prevention of Nuclear War (IPPNW), the organisation awarded the 1985 Nobel Peace Prize. In 2007, IPPNW co-founded the International Campaign to Abolish Nuclear Weapons (ICAN) which was awarded the 2017 Nobel Peace Prize.

Dr Muller visited Moscow in his work against nuclear arms four months before the invasion of Ukraine and he has spoken widely on the role of health professionals in the prevention of nuclear war. 

In his work as a cardiologist, along with Dr Peter Stone and Dr Geoff Tofler, Dr Muller is credited with introducing the term “vulnerable plaque” in 1989, a concept now widely used in cardiology which describes a build-up in the arteries which can break away and cause heart attack or stroke. 

Dr Muller is attending University of Galway as part of a meeting of international cardiologists, The Imperial Vulnerable Patient and Plaque Meeting, where he is a keynote speaker. 

The meeting, which runs from September 27-29 in Galway and is jointly organised by Imperial College London and University of Galway, serves as a think-tank and includes world-leading scientists, clinical opinion leaders, industry experts and decision makers. It is a unique opportunity to exchange knowledge skills and experience in the field of heart disease. 

This year marks the 20^th anniversary of the annual meeting with a multitude of technical advances and clinical trials having been conceived during the conference down through the years. The programme addresses the developments in fundamental mechanisms of the build-up of fats, cholesterol and other substances in and on the artery walls and the risks associated with this, along with recent developments in clinical trials in this area. 

Places for the public lecture are limited and registration is essential. To register or for more information visit https://bit.ly/3BkQ6R7. 

Ends